instit.oncol.cluj-napoca- sectia hematologie - 2012
instit.oncol.cluj-napoca- sectia hematologie - 2012
instit.oncol.cluj-napoca- sectia hematologie - 2012
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
18. Schema PEP-C (tratament metronomic)<br />
- Prednison 20mg/zi, zilnic sau 5 zile/saptamana<br />
- Etopozid 50mg/zi, zilnic sau 5 zile/saptamana<br />
- Procarbazina 50mg/zi zilnic sau 5 zile/saptamana<br />
- Ciclofosfamida 50mg/zi sau 5 zile/sapt<br />
BIBLIOGRAFIE<br />
1. A clinical evaluation of the International Lymphoma Study Group classification of non-<br />
Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project. Blood<br />
1997;89:3909-18.<br />
2. Jaffe ES et al. In Kleihues P, Sobin L (eds).WHO Classification of Tumors. ARC Press, Lyon.<br />
2001<br />
3. Harris NL et al. A revised European-American classification of lymhpoid neoplasms: a proposal<br />
from the International Lymphoma Study Group. Blood1994;84:1361-92.<br />
4. Greer JP, Foerster J, Lukens JN et al. Wintrobe’s Clinical Hematology.11 th Edition, Lippinkott<br />
Williams&Wilkins 2003.<br />
5. A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s<br />
Lymphoma Prognostic Factors. N Engl J Med 1993;329:987-94.<br />
6. J O Armitage. How I treat patients with diffuse large B-cell lymphoma. Blood 2007;110:29-36.<br />
7.NCCN Guidelines Version 3.2013. Non-Hodgkin’s Lymphoma<br />
http://www.nccn.org/professionals/physician_gls/pdf/nhl.pdf
Change language